Joe Cabral

Joe Cabral is a Principal at Frazier Life Sciences, a leading venture capital firm focused on life sciences and healthcare innovation. Based in Boston, MA, he brings over two decades of experience in biotechnology and venture capital, with a deep expertise in company creation, strategic development, and investment management. In his current role, Cabral is responsible for sourcing, evaluating, and executing early-stage investments, as well as supporting portfolio companies through growth and development. He is actively involved in guiding Frazier Life Sciences’ investment strategy, particularly in the areas of biopharmaceuticals, therapeutics, and technology-driven healthcare solutions.

Cabral’s investment focus spans biotechnology, pharmaceuticals, and innovative healthcare technologies, with a particular emphasis on early-stage and company creation opportunities. He leverages his extensive network and operational experience to identify promising startups and emerging scientific platforms, supporting them from inception through commercialization. His work often involves collaborating with entrepreneurs, scientists, and industry leaders to build and scale transformative life sciences ventures.

Prior to joining Frazier Life Sciences, Cabral was a Senior Associate at Flagship Pioneering, where he played a key role in the founding and development of Generate Biomedicines, Inc., a pioneering biotech company focused on generative biology. He holds an MBA from the University of Michigan’s Stephen M. Ross School of Business, which has equipped him with strong strategic and financial acumen. Throughout his career, Cabral has been recognized for his contributions to the venture capital and biotech communities, including his instrumental role in launching and scaling several successful life sciences startups.